newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

Announces a 1-for-35 Reverse Stock Split and Receipt of NYSE American Notice Regarding Stockholders' Equity NovaBay® Pharmaceuticals, Inc. the "Company") (NYSE:NBY) announces that a quorum was reached and that